While approximately 70% of all IMT cases show ALK fusions [81], predominantly RANBP2–ALK [82], it is notable that most CNS IMT cases documented in the literature lack ALK expression [83]. The gene discussed is RANBP2; the disease is inflammatory myofibroblastic tumor.